These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 17522695

  • 1. Underglycosylation of IgA in IgA nephropathy: more than a diagnostic marker?
    Roos A, van Kooten C.
    Kidney Int; 2007 Jun; 71(11):1089-91. PubMed ID: 17522695
    [Abstract] [Full Text] [Related]

  • 2. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
    Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J.
    Kidney Int; 2007 Jun; 71(11):1148-54. PubMed ID: 17342176
    [Abstract] [Full Text] [Related]

  • 3. Role of macromolecular IgA in IgA nephropathy.
    van der Boog PJ, van Kooten C, de Fijter JW, Daha MR.
    Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autoantibodies in IgA nephropathy.
    O'Donoghue DJ, Feehally J.
    Contrib Nephrol; 1995 Mar; 111():93-103; discussion 104-6. PubMed ID: 7758352
    [No Abstract] [Full Text] [Related]

  • 6. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Mar; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aberrant glycosylation in IgA nephropathy (IgAN).
    Coppo R, Amore A.
    Kidney Int; 2004 May; 65(5):1544-7. PubMed ID: 15086888
    [Abstract] [Full Text] [Related]

  • 9. IgA nephropathy--a disorder of IgA production?
    Feehally J.
    QJM; 1997 Jun; 90(6):387-90. PubMed ID: 9205676
    [No Abstract] [Full Text] [Related]

  • 10. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
    Segarra A.
    Nefrologia; 2010 Jun; 30(5):501-7. PubMed ID: 20882091
    [Abstract] [Full Text] [Related]

  • 11. [Therapy in IgA nephropathy--when and how to do it].
    Vas T, Kovács T, Késoi I, Sági B, Degrell P, Wittmann I, Nagy J.
    Orv Hetil; 2011 Dec 18; 152(51):2039-46. PubMed ID: 22130201
    [Abstract] [Full Text] [Related]

  • 12. IgA nephropathy and mucosal immune system.
    Nagura H.
    Tokai J Exp Clin Med; 1989 Mar 18; 14(1):1-4. PubMed ID: 2699951
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immune regulation in IgA nephropathy.
    Monteiro RC, Noël LH, Chevailler A, Halbwachs-Mecarelli L, Lesavre P.
    Nephrologie; 1989 Mar 18; 10(3):147-50. PubMed ID: 2691912
    [Abstract] [Full Text] [Related]

  • 15. Mesangial IgA in IgA nephropathy arises from the mucosa.
    Béné MC, Faure GC.
    Am J Kidney Dis; 1988 Nov 18; 12(5):406-9. PubMed ID: 3055966
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Application of mass spectrometry to IgA nephropathy: structural and biological analyses of underglycosylated IgA1 molecules.
    Yasuda Y, Horie A, Odani H, Iwase H, Hiki Y.
    Contrib Nephrol; 2004 Nov 18; 141():170-88. PubMed ID: 14650232
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.